G-Tech Medical
G-Tech Medical is a private, FDA-cleared medical device company that sells the GutTracker wireless dermal patch system for non-invasive, multi-day monitoring of gastrointestinal myoelectric activity. It serves gastroenterologists and surgical departments diagnosing functional GI disorders such as gastroparesis, IBS, IBD, and chronic constipation in the US market.
- Company typePrivate
- Founded2011
- HeadquartersMountain View, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What G-Tech Medical does
G-Tech Medical is a privately held, venture-backed medical device company headquartered at the Fogarty Innovation incubator on the El Camino Hospital campus in Mountain View, California. The company has developed GutTracker®, an FDA 510(k)-cleared wireless dermal patch system that continuously monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days. Signals are captured via skin-surface electrode patches, transmitted over Bluetooth to a smartphone application, and forwarded to a secure cloud server where proprietary algorithms — developed from the CTO's particle physics background — assign signals to specific GI organs based on characteristic frequencies (stomach at 3 cpm, small intestine at 8-12 cpm, colon at 12-20 cpm) and generate a per-patient GutPrint® biomarker profile.
The company's primary products are the GutTracker patch system (currently in its Gen 2 form with a three-day battery), the companion smartphone app, and the cloud-based GutPrint® analysis. The platform is positioned as an EKG analog for the gastrointestinal tract and targets gastroenterologists diagnosing functional GI disorders (gastroparesis, IBS, IBD, chronic constipation) as well as surgical departments managing post-operative feeding and discharge decisions. The technology has been validated in 800+ clinical tests across leading US hospitals, supported by 7+ peer-reviewed publications and 30+ conference presentations.
G-Tech generates revenue through the sale of the disposable wireless patches and associated testing services to healthcare providers under physician prescription. The company has stated pricing is not publicly disclosed, consistent with quote-based medical device sales. Go-to-market is direct-to-provider, targeting gastroenterology practices and hospital systems exclusively in the United States. Key clinical partners have included Mayo Clinic (Jacksonville), El Camino Hospital, and the Parkinson's Institute, though these relationships are primarily research-based rather than commercial-customer relationships. The company is funded by DigiTx Partners, Breakout Labs (Thiel Foundation), EMV Capital, and the Kenneth Rainin Foundation, with leadership comprising a CEO (Scott Schorer) with healthcare turnaround and commercialization experience, a CTO/founder (Steve Axelrod, PhD) with physics and medical device backgrounds, and senior clinical and business development staff.
G-Tech Medical firmographics
Firmographics- Name
- G-Tech Medical
- Legal name
- G-Tech Medical
- Website
- https://gtechmedical.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- G-Tech Medical is a private, FDA-cleared medical device company that sells the GutTracker wireless dermal patch system for non-invasive, multi-day monitoring of gastrointestinal myoelectric activity. It serves gastroenterologists and surgical departments diagnosing functional GI disorders such as gastroparesis, IBS, IBD, and chronic constipation in the US market.
- Ownership category
- akta.pro rank
G-Tech Medical industry classification
Industry- Product category
- Gastrointestinal Diagnostic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industries
- General Gastroenterology (HLAKAEAA), Gastroenterology Telemedicine Platforms (HLALAGAE)
Keywords
Where G-Tech Medical is headquartered
LocationHeadquarters
- HQ city
- Mountain View
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
G-Tech Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Device and Testing Services: G-Tech Medical sells the GutTracker wireless patch system and associated testing services. The FDA-cleared device consists of wireless patches, a smartphone app, and cloud-based data analysis. The company generates revenue through the sale of patches and related testing services to healthcare providers and patients under physician supervision.
- Cloud Data Analysis: Proprietary algorithms analyze data in the cloud and provide patient-specific GI function insights. Data is transmitted from patches via Bluetooth to smartphone, then to secure cloud server for processing and physician report generation.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
G-Tech Medical product offering
Product offeringCore offering
G-Tech Medical develops and sells the GutTracker® system, an FDA 510(k)-cleared wireless dermal patch that non-invasively monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days. The patches transmit data via Bluetooth to a smartphone app, which forwards the data to a secure cloud server where proprietary algorithms analyze the signals and produce physician reports for diagnosing functional gastrointestinal disorders such as gastroparesis, IBS, IBD, chronic constipation, and post-surgical ileus.
Product overview
G-Tech Medical offers the GutTracker® system as its primary product—a comprehensive wireless dermal patch platform for gastrointestinal diagnostics. The system consists of wearable electrode patches (Gen 2), a smartphone app for Bluetooth data collection, cloud-based proprietary algorithms for signal analysis, and the GutPrint® output visualization. The platform functions analogously to an EKG for the gut, enabling multi-day monitoring of myoelectrical activity across the entire GI tract. The FDA-cleared device supports clinical decision-making for conditions including gastroparesis, Crohn's disease, chronic constipation, and post-operative recovery assessment.
Differentiator
Problem solved
Functional benefit
Brands
- GutTracker: FDA-cleared wireless dermal patch system for monitoring gastrointestinal motility by measuring myoelectrical signals from the stomach, small intestine, and colon over multiple days
- GutPrint
Products and services
- GutTracker® Wireless Patch System FDA-cleared wireless dermal patch system that monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days, providing clinicians with comprehensive GI motility data for diagnosis of functional gastrointestinal disorders. The system consists of wearable electrode patches (Gen 2 with three-day battery life and four bipolar electrode pairs), a Bluetooth-connected smartphone app, and cloud-based proprietary algorithms for signal analysis. Used under physician supervision by gastroenterologists and surgical departments.
Quantifiable outcome
- Outperformed gastric emptying scintigraphy (GES) in identifying patients with abnormal activity in Mayo Clinic study
- +4 more outcomes
Companies that use G-Tech Medical
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
G-Tech Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
G-Tech Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fogarty InnovationcoreG-Tech Medical is a 'Company in Residence' at Fogarty Innovation, located on the campus of El Camino Hospital in Mountain View, CA. Founded by Dr. Thomas J. Fogarty, an internationally recognized cardiovascular surgeon, inventor and entrepreneur named on over 200 medical device patents, Fogarty Innovation spurs medical device innovation to improve patient care and lower healthcare costs.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
G-Tech Medical competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic owns SmartPill (capsule-based GI motility diagnostic) and PillCam (capsule endoscopy), directly competing with G-Tech's wireless patch in GI motility assessment. As the dominant incumbent in GI diagnostics with established reimbursement and physician relationships, Medtronic is the primary competitive threat to GutTracker.
- Hologic: Hologic operates in women's health diagnostics including GI-adjacent imaging and surgical tools. As a large public medtech with established hospital sales infrastructure, Hologic represents a potential strategic acquirer or competitive benchmark for G-Tech's GI diagnostics business.
- Baxter International: Baxter has a significant medical devices and patient monitoring portfolio and serves hospital systems globally. Its patient monitoring business overlaps conceptually with G-Tech's at-home GI monitoring paradigm, and it represents both a competitive incumbent and potential strategic exit path.
- Philips (Royal Philips): Philips has a large connected care and patient monitoring business, plus GI imaging (legacy Philips Medical) capabilities. Its established hospital sales channels and remote patient monitoring infrastructure make it a relevant incumbent and potential strategic acquirer for G-Tech.
Emerging players
- iRhythm Technologies: iRhythm commercialized the Zio wearable cardiac monitoring patch, which uses a similar wearable-patch-plus-cloud-algorithmic-analysis business model to G-Tech. Its successful commercialization validates the wearable diagnostic + cloud paradigm G-Tech is pursuing in GI, and advisor Dr. Uday Kumar co-founded iRhythm.
- Eko Health: Eko builds digital stethoscopes and AI-enabled auscultation devices that capture physiologic signals and apply cloud-based AI diagnostics — the same signal-acquisition-plus-algorithmic-analysis model G-Tech uses for myoelectric GI signals.
- Bodyport: Bodyport develops a connected cardiovascular monitoring platform using a bathroom scale-like device to capture cardiac signals. It shares G-Tech's model of non-invasive, multi-day, at-home physiologic signal capture with cloud-based algorithmic interpretation.
- HeartBeam: HeartBeam develops a wearable, FDA-cleared cardiac monitoring device that captures ECG signals outside the clinical setting and applies cloud analysis. It is comparable in form factor, business model, and regulatory pathway to GutTracker.
- AliveCor: AliveCor's KardiaMobile is an FDA-cleared personal ECG device paired with AI cloud algorithms. It represents the same direct-to-physician / direct-to-patient wearable diagnostic + cloud analysis business model that G-Tech is bringing to GI motility.
Others
- Vivos Therapeutics: While not directly comparable in GI, Vivos is an example of a small FDA-cleared wearable-style medical device company navigating early commercialization — providing a peer benchmarking point for G-Tech's go-to-market trajectory as a small-cap medtech.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
G-Tech Medical social profiles
Digital presenceG-Tech Medical compliance and trust
Trust signalCompliance1 record
G-Tech Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
G-Tech Medical leadership team
Management profileNumber of profiles
Profiles8 records
G-Tech Medical funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
G-Tech Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about G-Tech Medical
What does G-Tech Medical do?
G-Tech Medical develops and sells the GutTracker® system, an FDA 510(k)-cleared wireless dermal patch that non-invasively monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days. The patches transmit data via Bluetooth to a smartphone app, which forwards the data to a secure cloud server where proprietary algorithms analyze the signals and produce physician reports for diagnosing functional gastrointestinal disorders such as gastroparesis, IBS, IBD, chronic constipation, and post-surgical ileus.
Is G-Tech Medical a public or private company?
G-Tech Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was G-Tech Medical founded?
G-Tech Medical was founded in 2011. It employs 1 to 10 people.
Where is G-Tech Medical based?
G-Tech Medical is headquartered in Mountain View, United States, in the North America region.
How does G-Tech Medical make money?
Two revenue lines are on record. Device and Testing Services are the primary driver. The others are cloud Data Analysis.
Who are G-Tech Medical's main competitors?
Broad incumbents on record are Medtronic, Hologic, Baxter International and Philips (Royal Philips). Emerging players are iRhythm Technologies, Eko Health, Bodyport, HeartBeam and AliveCor. Vivos Therapeutics is listed as an others.
Does G-Tech Medical have an API?
No public API is recorded for G-Tech Medical.
What industry is G-Tech Medical in?
G-Tech Medical's product category is Gastrointestinal Diagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAKAEAA, General Gastroenterology. Its NAICS code is 334510 and its SIC code is 3841.